Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
20 participants
INTERVENTIONAL
2025-07-15
2026-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Flap vascularization is a variable mechanism, complex to describe and understand. For cutaneous and subcutaneous (fatty) flaps, which account for the majority of flaps used, perforator flaps (vascularized by a subcutaneous perforator artery) have become the benchmark. Unfortunately, their vascularization is currently poorly understood, and depends on experimental work carried out on fresh cadaveric anatomical specimens. These cadaveric studies fail to take into account several key factors influencing perforasomes (perforasome: skin territory vascularized by a pedicle), namely body temperature, blood pressure, heart rate, intraoperative patient position and biological parameters.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perineal Flap Reconstruction Following Surgery for Advanced Pelvic Malignancy
NCT05074082
Comparing Different Surgical Techniques for Coverage of Pressure Ulcer
NCT04446936
Evaluation of the Cryopreserved Amniotic Membranes in the Care of Resistant Vascular Ulcers
NCT00820274
Pelvic Floor Reconstruction Using Biological Mesh With Negative Pressure Wound Therapy Following ELAPE
NCT04033484
Excision and Reconstruction of the Natal Cleft With a Parasacral Perforator Flap Versus Open Excision With Secondary Healing, in the Management of Sacrococcygeal Pilonidal Disease.
NCT03534700
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PeriCam and PeriFlux measurements
PeriCam and PeriFlux measurements
PeriCam and PeriFlux measurements
PeriCam and PeriFlux measurements
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PeriCam and PeriFlux measurements
PeriCam and PeriFlux measurements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Reconstructive surgery using pedicled perforating flap or free perforating flap.
* Flap with a surface area of at least 50 cm2 (in order to have a sufficiently large surface area for good perfusion visualization)
* Pedicled perforating flaps group: Patients with pelvic eschar
* Free perforating flaps group: Traumatic pathology of the lower and/or upper limb
Exclusion Criteria
* No social security affiliation
* Persons under court protection
* Persons participating in another study with an exclusion period still in progress
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-A00951-48
Identifier Type: OTHER
Identifier Source: secondary_id
RECHMPL25_0082
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.